Tag Jillian R. Gunther

Introduction As early as the 1970s, proton therapy was considered a promising treatment for hematologic malignancies, specifically for use in total nodal irradiation, the historic standard of care treatment for Hodgkin lymphoma (HL). In one report, it was recognized that…